Hitoshi Odagiri
Directeur/Bestuurslid bij SUMITOMO PHARMA CO., LTD.
Oorsprong van het eerstegraads netwerk van Hitoshi Odagiri
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 33 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Hitoshi Odagiri via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| RESONA HOLDINGS, INC. | Regional Banks | Director/Board Member | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| NEC CORPORATION | Information Technology Services | Chairman | |
| KOBE STEEL, LTD. | Steel | Chief Executive Officer | |
Resona Bank Ltd.
 Resona Bank Ltd. Regional BanksFinance Resona Bank, Ltd. provides commercial banking services. It operates through the following segments: Personal, Corporate, and Market. The Personal segment handles financial services for individual customers including personal loans, asset management, and inherited asset consulting. The Corporate segment focuses on lending, asset management that uses trusts, real estate operations, enterprise pensions, and business growth support. The Market segment engages in funds, foreign and local exchanges, bonds, and derivatives. It also offers current and savings accounts, mortgages, debit and credit cards, pension and insurance products, online and phone banking, and investment trusts. The company was founded on May 15, 1918 and is headquartered in Osaka, Japan. | Regional Banks | Director/Board Member | |
| GURUNAVI, INC. | Internet Software/Services | Director/Board Member | |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Tolero Pharmaceuticals, Inc.
 Tolero Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Tolero Pharmaceuticals, Inc. manufactures and markets pharmaceutical products. It is a clinical-stage biopharmaceutical company with a single-minded purpose to alleviate human suffering through the development of medicines to treat cancer and other serious human diseases. The company is headquartered in Lehi, UT. | Pharmaceuticals: Other | Director/Board Member | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SUMITOMO MITSUI FINANCIAL GROUP, INC. | Major Banks | Director/Board Member | |
| TOKIO MARINE HOLDINGS, INC. | Property/Casualty Insurance | Director/Board Member | |
| SUMITOMO CHEMICAL CO., LTD. | Chemicals: Specialty | Corporate Officer/Principal | |
| SUMITOMO ELECTRIC INDUSTRIES, LTD. | Electrical Products | Director/Board Member | |
| LIXIL CORPORATION | Building Products | Director/Board Member | |
| NITTO DENKO CORPORATION | Electronic Equipment/Instruments | Director/Board Member | |
| IHI CORPORATION | Industrial Machinery | Director/Board Member | |
| HOUSE FOODS GROUP INC. | Food: Specialty/Candy | Director/Board Member | |
| SEIKO GROUP CORPORATION | Other Consumer Specialties | Director/Board Member | |
| THE ROYAL HOTEL, LIMITED | Hotels/Resorts/Cruise lines | Director/Board Member | |
| JCR PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Sumitomo Mitsui Banking Corp.
 Sumitomo Mitsui Banking Corp. Major BanksFinance Sumitomo Mitsui Banking Corp. engages in the provision of financial services centered on banking. It operates through the following business segments: Wholesale, Retail, International, Market Sales, and Headquarters Management. The Wholesale segment covers business for customers of large and medium-sized companies in Japan. The Retail segment handles business for domestic individuals and SME customers. The International segment comprises of business for overseas Japanese and non-Japanese companies. The Market Sales segment corresponds to financial market business. The Headquarters Management segment includes all other businesses not covered by other segments. The company was founded in April 2001 and is headquartered in Tokyo, Japan. | Major Banks | Director/Board Member | |
The Japan Research Institute Ltd.
 The Japan Research Institute Ltd. Miscellaneous Commercial ServicesCommercial Services The Japan Research Institute Ltd. is a 'knowledge engineering' company, a company that offers information services, through the coordinated application of its three functions, that is, information systems, consulting, and think-tank. As a systems integrator, the company offers services in information technology (IT) strategy planning, implementation and outsourcing for a broad range of industries and activities. The company is also active in research of both domestic and foreign economic issues and formation of policy recommendation, as well as consulting in fields, such as corporate strategies and public administrative reform. In addition, the firm provides analyses and surveys for incubation activities in the creation of new markets and industries. Through these operations The Japan Research Institute offers a vision to its customers towards changes in the economic and social environment as well as developments in the IT area. | Miscellaneous Commercial Services | Chairman | |
| SEIKO EPSON CORPORATION | Computer Peripherals | Chairman | |
| ANGES, INC. | Pharmaceuticals: Generic | Director/Board Member | |
Kyoto Pharmaceutical Industries Ltd.
 Kyoto Pharmaceutical Industries Ltd. Pharmaceuticals: MajorHealth Technology Kyoto Pharmaceutical Industries Ltd. engages in pharmaceutical products manufacturing. Its products include pharmaceuticals to regulate high-blood pressure, Ischemic heart disease treatment, digitalis formulation, and constipation remedies. The firm also develops and produces laxatives, anti-flatulence and anti-diarrheal medicines, and decongestants and cold medicines. The company was founded on September 5, 1946 and is headquartered in Kyoto, Japan. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Kyushu University | College/University | Graduate Degree | |
| University of Tokyo | College/University | Graduate Degree Undergraduate Degree | |
| Tokyo Institute of Technology | College/University | Doctorate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
| Hiroshima University | College/University | Doctorate Degree | |
| JAPAN POST INSURANCE CO., LTD. | Life/Health Insurance | Director/Board Member | |
Nihon Medi-Physics Co., Ltd.
 Nihon Medi-Physics Co., Ltd. Pharmaceuticals: MajorHealth Technology Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura. | Pharmaceuticals: Major | Chief Executive Officer | |
NEC Asia Pacific Pte Ltd.
 NEC Asia Pacific Pte Ltd. Information Technology ServicesTechnology Services NEC Asia Pacific Pte Ltd. provides computer software solutions. Its solutions and services include digital signage, ERP, infrastructure, managed services and outsourcing, RFID, public safety solutions and services, unified communications and virtual PC center. The company was founded in 1977 and is headquartered in Singapore. | Information Technology Services | Chairman | |
| National Police Agency | General Government | Director/Board Member | |
| RENESAS ELECTRONICS CORPORATION | Semiconductors | Director/Board Member | |
| Financial Services Agency | General Government | Corporate Officer/Principal | |
| JAPAN EXCHANGE GROUP, INC. | Investment Banks/Brokers | Director/Board Member | |
Primetals Technologies Ltd.
 Primetals Technologies Ltd. Information Technology ServicesTechnology Services Primetals Technologies Ltd. operates as a engineering and plant construction company. It manures of steel and iron products. The company was founded in January 2015 and is headquartered in London, the United Kingdom. | Information Technology Services | Director of Finance/CFO | |
Sunovion Pharmaceuticals Europe Ltd.
 Sunovion Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Sunovion Pharmaceuticals Europe Ltd. is a British European pharmaceutical company founded in 2013 that is dedicated to improving the lives of patients through the supply of essential medicines. The company is based in London, UK. The company commercializes and distributes a portfolio of specialty brands and hospital products in 40 countries worldwide, both directly and through strategic partnerships. The company's vision is to become a recognized partner of choice through their commercial excellence, patient focus, and presence across the globe. Sunovion Pharmaceuticals Europe aims to have a positive impact on society through their pioneering focus on their environment, social, and governance (ESG) goals. | Pharmaceuticals: Major | Chief Executive Officer | |
Meltin MMI KK
 Meltin MMI KK Medical SpecialtiesHealth Technology Meltin MMI KK develops bio-signal interface technologies. It offers biosignal processing and cable-driven ststems. The company was founded by Sumio Ito, Masahoro Kasuya and Tatsuya Seki and is headquartered in Tokyo, Japan. | Medical Specialties | Director/Board Member | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member Director/Board Member | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member | |
| Pancreas Research Foundation of Japan | Chairman | ||
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| TOKYU FUDOSAN HOLDINGS CORPORATION | Real Estate Development | Director/Board Member |
Statistieken
Internationaal
| Japan | 38 |
| Verenigde Staten | 8 |
| Verenigd Koninkrijk | 5 |
| Singapore | 2 |
| Bermuda | 2 |
Sectoraal
| Health Technology | 16 |
| Finance | 10 |
| Consumer Services | 6 |
| Technology Services | 5 |
| Electronic Technology | 5 |
Operationeel
| Director/Board Member | 72 |
| Corporate Officer/Principal | 33 |
| Independent Dir/Board Member | 19 |
| Chairman | 10 |
| President | 9 |
Sterkste connecties
- Beurs
- Insiders
- Hitoshi Odagiri
- Bedrijfsconnecties
